Assessing surrogacy using restricted mean survival time ratio for overall survival in non-small cell lung cancer immunotherapy studies is a research paper published in Chinese Clinical Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2U10CA180822-06
NRG Oncology - Statistical and Data Management Center
National Institutes of Health
Grant: 5P01CA142538-09
Statistical Methods for Cancer Clinical Trials
National Institutes of Health
Grant: 1R01AG066883-01
Empower treatment effects evaluation of randomized clinical trials for elderly patients with integrated real-world data
FWCI
0.44
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals